CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −10,000 | $208.65 | $2.1M | 0 |
| 2026-08-06 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −4,660 | $213.95 | $997K | 7,229 |
| 2026-08-05 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −45,004 | $212.01 | $9.5M | 7,229 |
| 2026-07-01 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −49,666 | $240.25 | $11.9M | 7,229 |
| 2026-06-11 | JEFFS ROGER Director | Sale 10b5-1 | −286 | $249.12 | $71K | 58,367 |
| 2026-06-10 | JEFFS ROGER Director | Sale 10b5-1 | −286 | $246.18 | $70K | 58,653 |
| 2026-06-10 | Mahony Susan Director | Sale 10b5-1 | −300 | $246.18 | $74K | 829 |
| 2026-06-10 | Coleman Mark Director | Sale 10b5-1 | −643 | $249.00 | $160K | 30,389 |
| 2026-06-09 | Mahony Susan Director | Sale 10b5-1 | −300 | $237.21 | $71K | 1,129 |
| 2026-06-09 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −49,670 | $241.01 | $12.0M | 7,229 |
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −33,000 | $240.09 | $7.9M | 42,867 |
| 2026-06-02 | Coleman Mark Director | Sale 10b5-1 | −5,537 | $223.39 | $1.2M | 29,603 |
| 2026-06-01 | Coleman Mark Director | Sale 10b5-1 | −6,000 | $230.30 | $1.4M | 35,140 |
| 2026-05-29 | Coleman Mark Director | Sale 10b5-1 | −6,000 | $233.46 | $1.4M | 41,140 |
| 2026-05-05 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −233 | $228.18 | $53K | 0 |
| 2026-05-04 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −4,517 | $227.94 | $1.0M | 0 |
| 2026-04-22 | Maizel Ari Chief Commercial Officer | Sale 10b5-1 | −7,500 | $182.42 | $1.4M | 0 |
| 2026-02-26 | Coleman Mark Director | Sale 10b5-1 | −25,000 | $161.11 | $4.0M | 47,140 |
| 2026-02-26 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −35,378 | $161.88 | $5.7M | 0 |
| 2026-02-02 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −32,410 | $185.60 | $6.0M | 7,229 |
Page 1 of 4 · 73 trades